Podcasts about Phase 3

This week, we're taking a look back at more of the action figures from Star Wars: The Black Series! 2020 is just getting started & UP for review this week are the Vehicles, Creatures and Deluxe Releases. There's Heroes, droids, and a certain little green fellow who knows the Force! Find out which figure came out on top and which ones left us wanting more. The votes have been cast... which figure will take the prestigious Jek Porkins' Medal of BadAssery?!?Originally aired October 27, 2025.Allada by Kevin MacLeod is licensed under a Creative Commons Attribution 4.0 license. https://creativecommons.org/licenses/...Source: http://incompetech.com/music/royalty-...Artist: http://incompetech.com/creativecommons.orgTrack - GalacticFilmstro | Create custom royalty-free music in minutes https://filmstro.com/Track - DestinyFilmstro | Create custom royalty-free music in minutes https://filmstro.com/

This week, we're taking a look back at more of the action figures from Star Wars: The Black Series! We've finally arrived in 2020! UP for review this week are the Figures from the 2020 Convention Exclusives & Special Releases. There's Heroes from Endor! Creatures from Hoth! and one very special Child! Find out which figure came out on top and which ones left us wanting more. The votes have been cast... which figure will take the prestigious Jek Porkins' Medal of BadAssery?!? Originally aired October 19, 2025.Track - GalacticFilmstro | Create custom royalty-free music in minutes https://filmstro.com/Track - DestinyFilmstro | Create custom royalty-free music in minutes https://filmstro.com/

Coming up: He's home. A father of two and husband of a seriously ill mother is reunited with his family after he was released from ICE detention. This comes after the surprising ruling of an immigration judge. Ramon Lopez brings us this exclusive.  Next: The Bay - the big park project near downtown Sarasota - is expanding north, into the next two phases. We have the details. Then: Gotta go? Hopefully not during a city commission meeting. Suncoast Searchlight brings you breaking news about plumbing at Sarasota City Hall.Finally: Manatee County is opening up public use of a big chunk of county-owned agricultural land near Lakewood Ranch.

Note: We apologize for the audio issues in this episode.This week, we're taking a look back at more of the action figures from Star Wars: The Black Series! UP for review this week are the Figures from the 2019 Waves 22 & 23. There's Inquisitors, Mandalorians, Rangers of the New Repluic and more! Find out which figure came out on top and which ones left us wanting more. The votes have been cast... which figure will take the prestigious Jek Porkins' Medal of BadAssery?!?Originally aired October 13, 2025.​​Allada by Kevin MacLeod is licensed under a Creative Commons Attribution 4.0 license. https://creativecommons.org/licenses/...Source: http://incompetech.com/music/royalty-...Artist: http://incompetech.com/creativecommons.orgTrack - GalacticFilmstro | Create custom royalty-free music in minutes https://filmstro.com/Track - DestinyFilmstro | Create custom royalty-free music in minutes https://filmstro.com/

We asked a simple, generative question: Which systems have we replaced, and with what alternatives? A clear chorus answers: we've lost too much to speed and spectacle, and we're committed to building slower, more human infrastructures of care. Across voices, we hear a shift from optimization to stewardship, from extraction to relation, from technology to meaning. “We've emphasized education and the arts and rethought our political infrastructure for something more humane.” —Radha M. This is a practical imagination. It doesn't trade in slogans; it drafts replacements—communication that protects dignity, mobility that privileges access, governance that codes care, and practices that rehearse the futures we want. Which system will you replace—and what will you grow there instead? Learn more about Deem at www.deemjournal.com

Send a Text Message. Please include your name and email so we can answer you! Please note, this does not subscribe you to our email list, it's just to answer if you have a questions for us. The excitement of those first 6–12 months has faded. The scale isn't moving like before, your body feels different, and suddenly year two of GLP-1 treatment doesn't feel straightforward anymore.This is where many people hit a wall. Progress slows, plateaus arrive, and it's easy to worry you're failing. After months of rapid changes, the slower pace feels frustrating… even defeating. Add in metabolic adaptations and the pressure of maintaining new habits, and year two can feel like uncharted territory.But this isn't the end of your progress. In fact, it's where sustainable success begins. In this episode, we'll explore what to expect in year two and beyond, including:Three key mindset shifts to help you thrive past year oneWhy plateaus don't mean your medication stopped working (and what to do instead)How to use non-scale victories to stay motivated when the numbers won't budgeSmart strategies to adapt your nutrition, movement, and habits as your body changesIf you've been wondering "what now?" after year one, this episode will give you the framework to tackle year two with confidence!ReferencesEp 139: Why "Stopped Working" Is the Wrong Way to Think About GLP-1 PlateausGet Your FREE 3-Day Hunger Hormone Reset Mini Video SeriesJoin the January round of The 30/30 ProgramAudio Stamps00:30 - Introduction to what to expect in year two and beyond on GLP-1s, including the three essential shifts for long-term success.01:45 - Shift #1: Moving from rapid to steady progress and learning to celebrate non-scale victories when the numbers slow down.05:34 - Shift #2: Understanding metabolic adaptations and the ongoing adjustments needed for dose, movement, protein, and sleep.09:24 - Shift #3: Moving into maintenance mode and building the "I do it anyway" identity where healthy habits happen no matter what.10:50 - Recap of the three key mindset shifts needed for sustainable long-term success on GLP-1.11:25 - Why maintenance is an active process that requires ongoing adjustments, just like maintaining a hotel or home over time.13:55 - January 30/30 enrollment is now open with capped group size for optimal support.All of the information on this podcast is for general informational purposes only. Please talk to your physician and medical team about what is right for you. No medical advice is being on this podcast. If you live in Indiana or Illinois and want to work with doctor Matthea Rentea, you can find out more on www.RenteaClinic.com ✨ Season 2 of Behind the Curtain is officially live! ✨ You can join the season on its own or take it a step further by opting into the live 21-Day Challenge with Dr. Rentea, running December 1–21—the perfect way to finish the year strong and head into the holidays with momentum.

The emerging therapy improved vision for some participants in an earlier clinical trial.

Candel Therapeutics CEO Dr. Paul Peter Tak joined Steve Darling from Proactive to highlight new subgroup analyses from the company's positive Phase 3 clinical trial of CAN-2409 in patients with intermediate-to-high-risk localized prostate cancer. The data were presented at the 2025 Annual Meeting of the American Society for Radiation Oncology or ASTRO. Radiation therapy remains the standard of care for this patient population but has seen little advancement in more than two decades. Despite current treatments, approximately 30% of patients experience disease recurrence within 10 years, underscoring a significant unmet need. The pivotal Phase 3 study was a randomized, double-blind, placebo-controlled, multicenter trial enrolling 745 patients. Participants were randomized 2:1 to receive either CAN-2409 plus valacyclovir in combination with standard-of-care radiation therapy or standard-of-care radiation alone. The investigational therapy was administered both before and during radiation treatment. The trial met its primary endpoint, demonstrating 30% improvement in disease-free survival, 38% improvement in prostate cancer-specific disease-free survival and at two years, a pathological complete response rate of 80.4% in the CAN-2409 arm, compared with 63.6% in the control arm. Importantly, Candel presented additional subgroup analyses showing that the efficacy of CAN-2409 was consistent regardless of the radiation modality used in the trial. This independence underscores the broad applicability of the therapy across different treatment settings. Dr. Tak emphasized the significance of the findings, noting that CAN-2409 represents the first potential advancement in localized, non-metastatic prostate cancer in more than 20 years. #proactiveinvestors #candeltherapeuticsinc #nasdaq #cadl #CancerTreatment #ViralTherapy #ProstateCancer #PancreaticCancer #Glioblastoma #PaulPeterTak #ClinicalTrials #BiotechNews #Immunotherapy #Oncology #CancerResearch

Soybean Cyst Nematode (SCN) is the most destructive pathogen of soybeans in the United States with annual yield losses due to SCN estimated at more than $1 billion. Yield losses caused by SCN are often underestimated because the nematode can be present in fields without causing any noticeable aboveground symptoms. In an effort to increase soybean farmers' awareness of soybean cyst nematode, the SCN Coalition is naming October 6, 2025, National Nematode Day. Recently members of the SCN Coalition met in Columbus, Ohio to discuss the latest research and updates on their current initiatives. On this episode of the Ohio Field Leader Podcast Greg Tylka, Professor in the Department of Plant Pathology and Microbiology at Iowa State University; Geroge Bird, Professor Emeritus in the Department of Entomology at Michigan State University; and Albert Tenuta, Extension Plant Pathologist at the Ontario Ministry of Agriculture, Food, and Agribusiness at the University of Guelph all joined the Ohio Field Leader to discuss the origins of the SCN Coalition and share their vision for the future.

We're back at full speed! In this episode, we dive into Marvel Zombies on Disney+—all 4 episodes, the big bad Undead Queen Mother, and how it connects to the MCU. Then we rewind to Marvel's Phase 3 with fresh takes, rank the Top 20 from the PWI 500 list, and share thoughts on John Cena's possible final match.That's not all—we crack open one of Evo's custom Pokémon binders built from extra bulk, play the game Is This a Rock Band or a Pokémon?, and ask the community to weigh in on Reboot or Leave It: 90s Cartoons Edition.✨ Call to Action: This October, we're crowning TWO champions—the Halloween Candy Champion and the 90s Horror Movie Champion! What's your favorite candy? What's your ultimate 90s horror flick? Let us know, and your pick might take the crown.Check out these delicious treats from ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Cakes and More By Sabrina⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Fulltime home baker. Let her be your cake lady.Listen to other amazing podcasters or just hang out with our amazing network by following our socials. For more on that check us out at.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠linktree.com/m3pnetwork⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Become a member of the My 3rd Place Network Community and watch me live stream the podcast nightly on⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠tiktok/evolutionofageek⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠email us m3pnetwork@gmail.com

Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives! In this episode, cohosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirector of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospital Diabetes and Metabolic Care Center, discuss the recently published results of the ATTAIN-1 and STEP UP clinical trials, both of which were presented at the European Association for the Study of Diabetes (EASD) 2025 Conference. 00:00:00 Introduction 00:00:32 ATTAIN-1 00:04:07 GLP-1s as a Daily Pill 00:08:20 Possible Lower GLP-1 Prices 00:09:03 STEP UP 00:11:41 Cardiovascular Protection with GLP-1s 00:12:48 GI Side Effects of Semaglutide 7.2 00:16:16 3 Times the Dose, 3 Times the Cardiovascular Protection? 00:17:20 Outro

Hive Digital Technologies CEO Aydin Kilic joined Steve Darling from Proactive to announce a significant achievement for the company — surpassing 20 Exahash per second (EH/s) of global Bitcoin mining capacity. This milestone comes on the heels of the continued rollout of advanced ASIC miners at HIVE's Phase 3 Valenzuela facility in Paraguay. Kilic explained that Phase 3 marks the company's third major 100-megawatt project in Paraguay, powered entirely by renewable hydroelectric energy from the world-renowned Itaipu Dam. This expansion underscores HIVE's long-term commitment to building sustainable, environmentally responsible Bitcoin mining operations while scaling its global footprint. The results so far have been substantial. HIVE has grown its hashrate by approximately 233% year-to-date and is currently producing around nine Bitcoin per day at a fleet efficiency of 18 Joules per Terahash (J/TH). Importantly, the company is achieving a healthy 55% mining margin after electricity costs, demonstrating the profitability of its green-energy-powered infrastructure. At present, HIVE's operations account for roughly 2% of the entire Bitcoin network, based on the current network difficulty of 142 trillion. With Phase 3 construction now largely complete and installations advancing ahead of schedule, HIVE recently surpassed its interim goal of 19 EH/s, ultimately pushing the company's global fleet to 20 EH/s. This marks a critical milestone in its strategic roadmap to reach 25 EH/s by U.S. Thanksgiving later this year. Looking ahead, once Phase 3 is fully completed, HIVE expects its daily Bitcoin production to increase to approximately 12 BTC, while further improving efficiency to around 17.5 J/TH. This scaling effort positions the company to strengthen its role as one of the leading players in sustainable Bitcoin mining worldwide. #proactiveinvestors #hivedigitaltechnologieslet #tsxv #hive #nasdaq #hive #CryptoMining #GreenEnergy #BitcoinMining #ParaguayMining #DataCenter #Exahash #S21Miners #DigitalAssets #ProactiveInvestors

This week, we're taking a look back at more of the action figures from Star Wars: The Black Series! UP for review this week are the Figures from the 2019 Wave 21. There's droids, heroes, villains and more! Find out which figure came out on top and which ones left us wanting more. The votes have been cast... which figure will take the prestigious Jek Porkins' Medal of BadAssery?!? Originally aired September 21, 2025.Allada by Kevin MacLeod is licensed under a Creative Commons Attribution 4.0 license. https://creativecommons.org/licenses/...Source: http://incompetech.com/music/royalty-...Artist: http://incompetech.com/creativecommons.orgTrack - GalacticFilmstro | Create custom royalty-free music in minutes https://filmstro.com/Track - DestinyFilmstro | Create custom royalty-free music in minutes https://filmstro.com/

In this bonus episode we give you the finale of the Battle for Hive Perdition, how has it gone - who has won?

This week we have a series of podcasts where we will be tier ranking all the MCU films and TV shows. This third episode covers Phase 3 of the MCU film releases. If you want to watch along their is a video version over on our YouTube channel right here : www.youtube.com/@whatwevewatchedpodcast9893

This week, we're taking a look back at more of the action figures from Star Wars: The Black Series! UP for review this week are the 2019 Wave 20 plus Deluxe Figures. There's droids, heroes, villains, Mandalorians and more! Find out which figure came out on top and which ones left us wanting more. The votes have been cast... which figure will take the prestigious Jek Porkins' Medal of BadAssery?!?Originally aired September 14, 2025.Allada by Kevin MacLeod is licensed under a Creative Commons Attribution 4.0 license. https://creativecommons.org/licenses/...Source: http://incompetech.com/music/royalty-...Artist: http://incompetech.com/creativecommons.orgTrack - GalacticFilmstro | Create custom royalty-free music in minutes https://filmstro.com/Track - DestinyFilmstro | Create custom royalty-free music in minutes https://filmstro.com/

Tonix Pharmaceuticals Holdings CEO Dr Seth Lederman joined Steve Darling from Proactive to share that the company presented four scientific posters at the PAINWEEK 2025 conference in Las Vegas, Nevada, showcasing robust data from two pivotal Phase 3 trials of Tonmya® for the treatment of fibromyalgia. The first study, RELIEF, was a 14-week randomized, double-blind, placebo-controlled trial, while the second, RESILIENT, served as a confirmatory efficacy and safety trial. Results across both studies demonstrated that Tonmya significantly reduced fibromyalgia-related pain while maintaining a favorable tolerability profile. Unlike conventional pain therapies, Tonmya is designed to pharmacologically target nonrestorative sleep by antagonizing receptors that regulate sleep architecture—addressing a central mechanism thought to perpetuate fibromyalgia symptoms. Dr. Lederman noted that beyond reducing pain, Tonmya's mechanism of action may help improve a wide spectrum of fibromyalgia symptoms, potentially supporting earlier diagnosis, timely intervention, and improved long-term outcomes. Importantly, the therapy represents a non-opioid treatment option at a time when safer alternatives are in high demand. With FDA approval secured, Tonix is now preparing to launch Tonmya commercially in the coming quarter, marking a transformative milestone for both the company and the fibromyalgia community. #proactiveinvestors #tonixpharmaceuticalsholdingcorp #nasdaq #tnxp #Biotech #TonixPharmaceuticals #Tonmya #Fibromyalgia #FDAApproval #NonOpioid #PainManagement #ChronicPain #NociplasticPain #Cyclobenzaprine #MoveFibroForward #Painweek2025

This week, we're taking a look back at more of the action figures from Star Wars: The Black Series! UP for review this week are the first batch of 2019 Disney Parks Exclusives. There's troopers, wookies, droids and pirates! Find out which figure came out on top and which ones left us wanting more. The votes have been cast... which figure will take the prestigious Jek Porkins' Medal of BadAssery?!? Originally aired September 7, 2025.Allada by Kevin MacLeod is licensed under a Creative Commons Attribution 4.0 license. https://creativecommons.org/licenses/...Source: http://incompetech.com/music/royalty-...Artist: http://incompetech.com/creativecommons.orgTrack - GalacticFilmstro | Create custom royalty-free music in minutes https://filmstro.com/Track - DestinyFilmstro | Create custom royalty-free music in minutes https://filmstro.com/

Graham Richardson, CFO of Faraday Copper (TSX:FDY – OTCQX:CPPKF), joins me to provide a comprehensive exploration update recapping the key milestones and discoveries from the 30,000 meter Phase 3 drill program, that is building into an updated Resource Estimate and more advanced update to the Preliminary Economic Assessment (PEA) due out in September.  Then we dive into the strategy and objectives for the upcoming 40,000 meter Phase 4 drill program, with a continued focus on defining, expanding, and testing new target all around the American Eagle Area at their 100% owned Copper Creek Project in Arizona.    The Copper Creek Project already has a 4.2 billion pound copper resource, and will be expanding as the drill results from the prior Phase 3 program are incorporated into the updated Resource Estimate, where it is anticipated to have a healthy portion in the indicated category.  With regard to the updated PEA, Graham highlights how much geotechnical and metallurgical work will be incorporated, making it a much more advanced PEA, and this is why the work programs after it is released will springboard over the PFS and go right into the Feasibility Study for 2026.   Graham and I discuss a number of the new discoveries made in Phase 3 at the new Banjo Breccia discovery, and recently discovered Winchester breccia, in addition to putting some holes into earlier-stage exploration targets at Old Reliable, the Sunrise Trend (which may indicate the presence of a new porphyry system),  and at Horsecamp. There were some holes in Phase 3 that targeted near-surface supergene copper mineralization with the goal of better understanding the distribution of oxide mineralization. Five holes were drilled near the Globe breccia and two near the Copper Giant breccia.  There will be more follow-up on this near-surface oxide mineralization as part of Phase 4.   In addition to expanding mineralization, testing new breccia targets, and infilling the American Eagle area in the upcoming Phase 4 drilling, there still will be some further definition holes drilled down into the deeper porphyry targets at the American Eagle and Keel deposits to better understand the geological controls and mineralization.   The company is well cashed up to complete all these work programs after announcing the closing of the CAD $49Million financing on July 29, 2025.  Graham also unpacks the strong roster of shareholders including the Lundin Family and Murray Edwards, as well as a number of institutional investment firms.  We wrap up discussing the infrastructure advantages and positives of operating in Arizona as a jurisdiction.     If you have any questions for Graham regarding Faraday Copper, then please email them to me at Shad@kereport.com.   In full disclosure, Shad is a shareholder of Faraday Copper at the time of this recording, and may choose to buy or sell shares at any time.   Click here to view the latest news from Faraday Copper

Susvimo is an FDA-approved treatment that continuously delivers drug through a tiny, implanted capsule

Karen along with her guest host Bob Ridgway, a realtor with Keller Williams, kick off the podcast with buying opportunities and listings right here in Ventura County. Their first guest is Justin Soenke with Phase 3, he is an expert in creating a website and online presence that gets your businesses phone to ring. Justin makes your website the final destination for customers that shows how you solve problems and create business Justin has been building websites for many years, hear how he creates the perfect one for you!  Next Karen & Bob talk insurance with Denise of Paladin Insurance Services.  From fire to earthquake, leak detection and more, Denise talks about insurance for your home and car... umbrellas too.  Denise is the local expert that explains this confusing world of insurance coverage in simple terms.  To close out the podcast Bob Davis invites everyone to The First Wednesday at Rocks & Drams in Ventura that will raise money for the Ronald McDonald Family Room in Ventura.  A fun "happy Hour", that raises cash for a great cause and lets you network too.  another awesome podcast from Girls On The Air!

Dr. Shuvro Roy and Dr. Daniel Blockmans discuss the efficacy and safety of upadacitinib as a treatment option for giant-cell arteritis.  Show reference:  https://www.nejm.org/doi/10.1056/NEJMoa2413449 

In this direct, no-nonsense episode of The Crying In My Cheesecake podcast, Dr. Danielle walks you through Phase 3 of the Roadmap to Health, where true healing reaches your brain, lymphatic system, and cellular level. This phase isn't a trendy cleanse—it's a foundational reset your body has been crying out for.She covers how toxins build up, why fatigue and symptoms can spike before they get better, and what it really takes to detox the body in alignment with how God designed it—not how diet culture or quick-fix medicine tells you to.If you've ever wondered why your brain feels foggy, your body feels swollen, or you're tired for no reason, this episode is your lightbulb moment.“I'm not going to slap a bandaid on your symptoms. I'm going to teach you how to heal—from the inside out.”Hit play, and take the next best step toward the life you were created for.SERVICES & MEMBERSHIPS:$7 Mentorship: How to Fix Your Energy, Cravings, and Mood in Just One Day

Dr. Shuvro Roy talks with Dr. Daniel Blockmans about the efficacy and safety of upadasatinib as a treatment option for giant-cell arteritis.  Read the related article in The New England Journal of Medicine.  Disclosures can be found at Neurology.org. 

Have questions? Submit them at hrask.org. Download our "READY. AAIM. PHIRE!" takeaway sheet for all the key insights from this episode. Click the link below: https://tinyurl.com/3zs43mhu On This Week at Work, we're exploring how to integrate AI - and Aaime Hart - into an everyday workflow that benefits your organization. Lauren demos how Aaime can unlock powerful insights from exit interview data, and we unpack why leaders must take ownership of both their organization's AI strategy and their personal conduct, especially in light of the recent CEO/HR dating scandal. Timestamps: 00:00 – Welcome to This Week at Work 00:46 – AI Strategy: From Tools to Transformation 01:41 – Recapping AI & HR Week with Lauren Patel 03:13 – Meet AAIME Hart: Safe AI for HR Professionals 05:16 – Hot Topic: Coldplay Scandal & Leadership Ethics 07:22 – Creative Ways HR is Using AI Today 09:58 – Transforming Exit Interviews with AI 15:08 – The Real Story Behind "Training" Feedback 24:10 – From Data to Action: AAIME's Turnover Reduction Plan 26:06 – One-Pager for Leadership: AI-Powered Insights

Phase 3 Wellness was established in 2004 releases information on how its new Negative Ion "Rain" Service service will change things in the Health and wellness space for the better. Further information can be found at https://www.phase3wellness.com/. Phase 3 Wellness City: Orlando Address: 4700 Millenia Blvd Suite 175 Website: https://phase3wellness.com Phone: +1-407-442-2715 Email: phase3wellness@gmail.com

The expanded Phase 1/2/3 shortens time to potential FDA approval.

In this episode of the HAE Speaks Podcast, Dr. Raffi Tachdjian (UCLA) and Pharvaris discuss the HAE CHAPTER-3 Study — a new HAE attack prevention trial currently enrolling. The study explores the safety and effectiveness of deucrictibant, an investigational once-daily oral treatment aimed at preventing HAE attacks.Thank you to Pharvaris for sponsoring this episode of the HAE Speaks Podcast!

Text us about COMICS! Or about whatever. It's your life. It's time to rank the MCU Phase 3!  Let's talk about Avengers Lite, planetary affairs, some REAL good Spider-Man, and the best team-up superhero movie TO DATE!  One, two, three, our opinions!New Episodes Every Week, mostly!Support us on Patreon! Get exclusive content! https://www.patreon.com/legionofcc SUBSCRIBE HERE: https://bit.ly/LegionOCCBrett Garwood - Man Behind The Curtain: https://redbagmedia.com/Our totally rad intro music comes from: Alex at Chop.it.up.productionsListen to our Podcast - Legion of Comic Correction - on all major podcasting platforms!Legion Website: legionofcc.comLCC Facebook: https://www.facebook.com/LegionofCC LCC Instagram: https://www.instagram.com/legionofcc/Support the show

De derde ronde, de ontknoping.... Vincent, Paul en special guests Wouter van de Sanden en Sam van Nielen maken hun nr 1 bekend....

Novo Nordisk end their partnership with Hims & Hers; update to Vizamyl labeling; autoinjector approved for pediatrics with lupus nephritis; psilocybin shows promise in treatment-resistant depression; sotatercept phase 3 trial results.

We gaan door! Ronde 2 van de Marvel Phase 3 ranking. Vincent en Paul ranken samen met special guests Wouter van de Sanden en Sam van Nielen...

Samen met special guests Wouter van de Sanden en Sam van Nielen ranken Paul en Vincent de 3e phase van de Marvel Cinematic Universe...

The Pinball Show Episode 177: Trough Jam 2025 Phase 3: Harry Potter & Predator Pinball   Hosts: Dennis Kriesel & Zach Meny   - Stern Pinball Production Updates - Stern Shares With Nintendo  - Jersey Jack Pinball Releases Harry Potter Pinball - First Impressions, Sales, Production, & Analysis Of Harry Potter - EXCLUSIVE MEMBERSHIP CONTENT: Reception & Sales Of Harry Potter Pinball - Predator Pinball Is Near - Trough Jam 2025 Extra Ball Coming Soon? - Pinball Market Trends™   EXCLUSIVE CONTENT AND TPS MEMBERSHIP CAN BE FOUND AT Patreon.com/thepinballshow   Remember to purchase your next pinball or arcade machine from Flip N Out Pinball! flipnoutpinball.com zach@flipnoutpinball.com greg@flipnoutpinball.com   Follow, like, and subscribe to The Pinball Show (TPS), the industry's most popular podcast!   email: thepinballshow@gmail.com youtube: youtube.com/thepinballshow instagram: @thepinballshowpodcast tik tok: @thepinballshow review: thisweekinpinball.com/the-pinball-show/ store: flipnoutpinball.com  

Gert Attard joins us to discuss this practice-changing data and the highlight of ASCO 2025

Chris rejoins us to finish off our 90's Infinity Saga castings!

Day 1 of Phase 3 Of Commanders OTA's is in the rear view mirror with most of the Commanders returning and new players taking the field... Logan and Craig breakdown who stood out most to them and which position groups are far deeper/shallower than they originally thought To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

Cover 2 with Blaine and Zach - Hour 1 - Titans OTA Phase 3 UpdatesSee omnystudio.com/listener for privacy information.

Hr 1- What is Phase 3 of OTA's?See omnystudio.com/listener for privacy information.

Send us a textJustin McDonald, St. Luke's Heart & Vascular Services director, joins Dr. Arnold to discuss the progress of St. Luke's $25 million dollar Heart and Vascular expansion and the final phase that's underway. To learn more about the project and about heart care services at St. Luke's Hospital, visit unitypoint.org/cr-heart. Do you have a question about a trending medical topic? Ask Dr. Arnold! Submit your question and it may be answered by Dr. Arnold on the podcast! Submit your questions at: https://www.unitypoint.org/cedarrapids/submit-a-question-for-the-mailbag.aspxIf you have a topic you'd like Dr. Arnold to discuss with a guest on the podcast, shoot us an email at stlukescr@unitypoint.org.

Hr 1- What is Phase 3 of OTA's?See omnystudio.com/listener for privacy information.

Cover 2 with Blaine and Zach - Hour 1 - Titans OTA Phase 3 UpdatesSee omnystudio.com/listener for privacy information.

Cover 2 with Blaine and Zach - Hour 1 - Vol Baseball entering Postseason + Titans Phase 3 StartsSee omnystudio.com/listener for privacy information.

Cover 2 with Blaine and Zach - Hour 1 - Vol Baseball entering Postseason + Titans Phase 3 StartsSee omnystudio.com/listener for privacy information.

The Pittsburgh Steelers are preparing for Phase 3 of OTAs this upcoming week, and there are plenty of storylines to track during this phase of offseason workouts. That is the topic of the Friday "Let's Ride" podcast with host Jeff Hartman, as well as the All Betz Are Off segment with Jeremy Betz and the Hart to Heart. This podcast is a part of the Steel Curtain Network, a proud member of the Fans First Sports Network. Learn more about your ad choices. Visit megaphone.fm/adchoices

Despite missing the primary endpoint, the treatment improved vision for some patients.

Synopsis: What does bold biotech leadership look like in 2025? In this episode of Biotech 2050, host Alok Tayi sits down with Stacy Lindborg, President & CEO of Imunon, to discuss bold innovation in ovarian cancer treatment and how harnessing the immune system through targeted gene therapy is reshaping survival outcomes. Stacy shares insights from her 30-year career—from her statistical roots at Eli Lilly to her mission-driven leadership at Imunon. She highlights the groundbreaking results from Imunon's IL-12 plasmid platform, which is showing a remarkable 13-month overall survival advantage in ovarian cancer patients and is now entering Phase 3 trials. They also discuss the evolving biotech landscape, how adaptive trial designs and AI are unlocking clinical potential, and why cultivating a bold, transparent company culture is key to advancing transformational science. Biography: Stacy R. Lindborg, PhD, was appointed President and Chief Executive Officer of Imunon in May 2024. Dr. Lindborg has served on Imunon's Board of Directors since June 2021. Dr. Lindborg has nearly 30 years of pharmaceutical and biotech industry experience with a particular focus on R&D, regulatory affairs, executive management and strategy development. She has designed, hired and led global teams, guiding long-term vision for growth through analytics and stimulating innovative development platforms to increase productivity. Prior to joining Imunon, Dr. Lindborg was Executive Vice President and Co-Chief Executive Officer at BrainStorm Cell Therapeutics where she will remain a member of the company's Board of Directors. At BrainStorm she was accountable for creating and executing clinical development strategies through registration and launch and progressed its novel cell therapy for ALS through a positive Phase 3 Special Protocol Assessment (SPA) study with the U.S. Food and Drug Administration. She interacted frequently with investors and analysts, represented the company in the scientific community as well as with the media, and played an active role in discussions with potential business partners. Dr. Lindborg previously was Vice President & Global Analytics and Data Sciences Head, responsible for R&D and marketed products at Biogen. She began her biopharmaceutical career at Eli Lilly and Company where over the course of 16 years she assumed positions of increasing responsibility, including Head of R&D strategy. Dr. Lindborg received an M.A. and Ph.D. in statistics, and a B.A. in psychology and math from Baylor University. She has authored more than 200 presentations and 90 manuscripts that have been published in peer-reviewed journals, including 20 first-authored. She has held numerous positions within the International Biometric Society and American Statistical Association and was elected Fellow in 2008.

Political involvement in the Avengers' affairs causes a rift between Captain America and Iron Man, and we're back to break it all down. Captain America: Civil War is episode 83 of Superhero Century, where we are watching every superhero movie in chronological order. 

Listen as coinvestigator and rheumatologist Dr. Andrea Rubbert-Roth reviews this Phase 3 trial of a JAKi in patients with giant cell arteritis. Dr. Rubbert-Roth discusses the latest results, including efficacy and safety outcomes.

Jared Isaacman was in Congress for a confirmation hearing for his nomination as NASA Administrator, which was followed up by reports of huge proposed budget cuts at NASA and NOAA. And as expected, SpaceX, ULA, and Blue Origin all received awards for NSSL Phase 3 Lane 2.This episode of Main Engine Cut Off is brought to you by 33 executive producers—nt, Frank, Joonas, Will and Lars from Agile, Pat from KC, Joakim (Jo-Kim), Josh from Impulse, Pat, Bob, Warren, Heiko, Steve, Theo and Violet, David, Kris, Donald, Joel, Fred, Jan, Lee, Russell, The Astrogators at SEE, Ryan, Matt, Stealth Julian, Tim Dodd (the Everyday Astronaut!), Better Every Day Studios, and four anonymous—and hundreds of supporters.TopicsIsaacman Insists NASA Can Pursue Moon and Mars Goals Simultaneously – SpacePolicyOnline.comTrump White House budget proposal eviscerates science funding at NASA - Ars TechnicaPlanetary Science Caucus Co-Chairs Bacon & Chu Statement on White House's Proposed Budget Cuts to NASA Science | U.S. Representative Don BaconNOAA budget proposal would affect weather satellite, other space programs - SpaceNewsSpaceX, ULA, Blue Origin win $13.7 billion in U.S. military launch contracts through 2029 - SpaceNewsSpace Force reassigns GPS satellite launch from ULA to SpaceX - SpaceNewsSpaceX secures majority of NSSL Phase 3 fiscal year 2025 missions - SpaceNewsThe ShowLike the show? Support the show on Patreon or Substack!Email your thoughts, comments, and questions to anthony@mainenginecutoff.comFollow @WeHaveMECOFollow @meco@spacey.space on MastodonListen to MECO HeadlinesListen to Off-NominalJoin the Off-Nominal DiscordSubscribe on Apple Podcasts, Overcast, Pocket Casts, Spotify, Google Play, Stitcher, TuneIn or elsewhereSubscribe to the Main Engine Cut Off NewsletterArtwork photo by FireflyWork with me and my design and development agency: Pine Works